240 related articles for article (PubMed ID: 2115096)
1. The CE plane: a graphic representation of cost-effectiveness.
Black WC
Med Decis Making; 1990; 10(3):212-4. PubMed ID: 2115096
[TBL] [Abstract][Full Text] [Related]
2. The augmented representation of the cost-effectiveness acceptability curve for economic evaluation of health technology.
Araki D; Kamae I
Kobe J Med Sci; 2015 Mar; 61(1):E9-18. PubMed ID: 25868612
[TBL] [Abstract][Full Text] [Related]
3. Health technology assessment in the cost-disutility plane.
Eckermann S; Briggs A; Willan AR
Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness concepts and the CE plane.
Ganiats TG
Med Decis Making; 1991; 11(2):147. PubMed ID: 1907709
[No Abstract] [Full Text] [Related]
5. Economic aspects of clinical decision making: applications in patient care.
Oster G
Am J Hosp Pharm; 1988 Mar; 45(3):543-7. PubMed ID: 3130753
[TBL] [Abstract][Full Text] [Related]
6. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.
Choi HK; Seeger JD; Kuntz KM
Arthritis Rheum; 2000 Oct; 43(10):2316-27. PubMed ID: 11037892
[TBL] [Abstract][Full Text] [Related]
7. On the (near) equivalence of cost-effectiveness and cost-benefit analyses.
Phelps CE; Mushlin AI
Int J Technol Assess Health Care; 1991; 7(1):12-21. PubMed ID: 1903360
[TBL] [Abstract][Full Text] [Related]
8. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?
Eichler HG; Kong SX; Gerth WC; Mavros P; Jönsson B
Value Health; 2004; 7(5):518-28. PubMed ID: 15367247
[TBL] [Abstract][Full Text] [Related]
9. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease.
Briggs AH; Goeree R; Blackhouse G; O'Brien BJ
Med Decis Making; 2002; 22(4):290-308. PubMed ID: 12150595
[TBL] [Abstract][Full Text] [Related]
10. Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects.
Armero C; García-Donato G; López-Quílez A
Health Econ; 2010 Jun; 19(6):629-43. PubMed ID: 19424994
[TBL] [Abstract][Full Text] [Related]
11. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.
Devlin N; Parkin D
Health Econ; 2004 May; 13(5):437-52. PubMed ID: 15127424
[TBL] [Abstract][Full Text] [Related]
12. Regression analysis of indicating multiple incremental cost-effectiveness ratios for non-small cell lung cancer treatment.
Nakahara N; Kamae I
J Med Econ; 2014 Aug; 17(8):547-54. PubMed ID: 24826807
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness. How should it be determined?
Beaves RG; Joseph H; Rohrer JE; Zeitler RR
Eval Health Prof; 1988 Jun; 11(2):213-30. PubMed ID: 10312609
[TBL] [Abstract][Full Text] [Related]
14. Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane.
Negrín MA; Vázquez-Polo FJ
Health Econ; 2006 Apr; 15(4):363-72. PubMed ID: 16259048
[TBL] [Abstract][Full Text] [Related]
15. The use and misuse of cost-effectiveness analysis.
Gaspari KC
Soc Sci Med; 1983; 17(15):1043-6. PubMed ID: 6414088
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands.
Visser K; de Vries SO; Kitslaar PJ; van Engelshoven JM; Hunink MG
Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):213-23. PubMed ID: 12623332
[TBL] [Abstract][Full Text] [Related]
17. An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.
Suen SC; Goldhaber-Fiebert JD
Med Decis Making; 2016 Jan; 36(1):132-6. PubMed ID: 25926282
[TBL] [Abstract][Full Text] [Related]
18. The impact of age on cost-effectiveness ratios and its control in decision making.
Baltussen R; Leidl R; Ament A
Health Econ; 1996; 5(3):227-39. PubMed ID: 8817297
[TBL] [Abstract][Full Text] [Related]
19. Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope.
Hoch JS; Rockx MA; Krahn AD
BMC Health Serv Res; 2006 Jun; 6():68. PubMed ID: 16756680
[TBL] [Abstract][Full Text] [Related]
20. Using propensity scores to estimate the cost-effectiveness of medical therapies.
Indurkhya A; Mitra N; Schrag D
Stat Med; 2006 May; 25(9):1561-76. PubMed ID: 16158412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
